Development, pharmacology and clinical experience with clomiphene citrate.
about
Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertilityClomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilizationClomiphene citrate for controlled ovarian stimulation in women undergoing in vitro fertilizationClomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic ImplicationsRisk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility.The impact of letrozole versus clomiphene citrate on uterine blood flow in patients with unexplained infertilityNew selective estrogen and androgen receptor modulatorsAcupuncture on the Endometrial Morphology, the Serum Estradiol and Progesterone Levels, and the Expression of Endometrial Leukaemia-inhibitor Factor and Osteopontin in RatsComparative evaluation of pregnancy outcome in gonadotrophin-clomiphene combination vs clomiphene alone in polycystic ovarian syndrome and unexplained infertility-A prospective clinical trial.Clomiphene citrate in the twenty-first century.Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trialInfertility evaluation and management. Strategies for family physiciansA prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome.Genetic Polymorphism of CYP2D6 and Clomiphene Concentrations in Infertile Patients with Ovulatory Dysfunction Treated with Clomiphene Citrate.Indirect androgen doping by oestrogen blockade in sports.Endometrial thickness and outcome in sub-fertile women treated with clomiphene citrate.Phenotypic and pharmacogenetic aspects of ovulation induction in WHO II anovulatory women.Management of polycystic ovary syndrome.The significance of anthropometric and endocrine parameters in ovulation induction with clomiphene citrate in women with polycystic ovary syndrome.Aromatase inhibitors for ovulation induction and ovarian stimulation.Polycystic ovary syndrome: an overview.Potential Teratogenic Effects of Clomiphene Citrate.Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1.Tamoxifen from Failed Contraceptive Pill to Best-Selling Breast Cancer Medicine: A Case-Study in Pharmaceutical Innovation.Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial.Luteal phase support in normo-ovulatory women stimulated with clomiphene citrate for intrauterine insemination: need or habit?Clomiphene citrate or aromatase inhibitors combined with gonadotropins for superovulation in women undergoing intrauterine insemination: a prospective randomised trial.Spontaneous pregnancy after clomiphene citrate failure.A comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on superovulation in Asian women with normal ovulatory cycles.Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome.Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.Comparison of human menopausal gonadotropin stimulation with and without clomiphene for in-vitro fertilisation in poor-responders.Ovulation Induction Using Clomiphene Citrate Using Stair - Step Regimen versus Traditional Regimen in Polycystic Ovary Syndrome Women - A Randomized Control Trial.Clomiphene treatment may be effective in refractory episodic and chronic cluster headache.The effect of luteal-phase support with vaginal progesterone on pregnancy rates in gonadotropin and clomiphene citrate/intra-uterine insemination cycles in unexplained infertility: A prospective randomised study.Tamoxifen is Better than Low-Dose Clomiphene or Gonadotropins in Women with Thin Endometrium (<7 mm) after Clomiphene in Intrauterine Insemination Cycles: A Prospective Study.Selective Estrogen Receptor ModulatorsMild versus conventional antagonist ovarian stimulation protocols in expected normal responders undergoing IVF/ICSI: a case–control study
P2860
Q24201431-5D2092EA-6087-4870-B36F-8C3C3610F707Q24202926-FF1082C8-909A-43F9-AFBA-E22EAE10AA9FQ24235151-679767DC-9730-4C83-892F-A4FC72946C4EQ28387522-5FE46DD8-5C5A-4388-9CA1-7BEFB3A86308Q30235061-1960CA6E-0B2C-462F-B18B-59206842B335Q33782981-852DA2C5-892C-402F-86A0-17D07C5EA6DCQ33814078-64E30CCF-D3C1-4D62-B4EA-2DAD21DD3AB2Q34211282-D20DF607-743D-4EBD-BD7E-90CFB0CF622FQ34268679-0D3DF74B-1C61-4078-920B-A116A8D92E8BQ34395382-262CFFAF-0381-4CE7-B5B6-0708213C43C1Q35102800-CF7EA9B2-1D0A-4BA5-BE5B-6BBF3E14BF9CQ35597951-EB732D3D-A4D2-4C17-B206-3A41636903ACQ36133360-698B5CDF-E574-4591-9C2C-DD5D6DDCEFFFQ36510024-AA385125-49AE-46B1-B62D-E5E2E09A215EQ36736110-3088FFFD-212F-43E4-B008-F54E417B486DQ37323650-6D9304D1-EB85-4069-A568-C22D2A11481FQ37466378-87EDCEF9-743B-4A3F-B65F-04C771E8ADC9Q37608413-59A92BC1-B610-48F8-8D89-863248FE5083Q37637705-632FC037-D365-48CD-89A9-4830AF8DC90DQ37862363-71C9D879-B46F-4C74-B519-6935BF5DC921Q37886072-871B22D3-D31E-4F2E-93FE-C094C181426FQ38762088-A6AE42A8-A9AF-42B8-884D-D5FEB58406B0Q41279919-493B05FD-1627-42D9-9AB1-5D1D825D6E74Q41684474-FCFD8579-0CB2-4CF2-A4A6-78C7E7F27A75Q42880659-ED3A58EB-50BB-4969-BD59-1473D4B07973Q42933733-B33B2A66-D2CC-4A41-BE52-FFC203A92DE0Q42940580-9CB542F0-132A-4F72-95C9-0657B964EB8BQ46673159-2D19BE5B-1D95-428B-BD23-F33F4FA49D9BQ46706682-ACAABF72-1181-4B35-A8C4-6CAF8734FE02Q47284714-D872CD51-4910-45CF-9EE0-82B37B786357Q47449419-FC223D8E-3833-4318-8D3F-EF2AD93FBC97Q48302057-460DE172-B139-4086-B94D-E0256CB81B30Q48597356-C4CCE234-142F-403C-AD89-3386E15CBA81Q49462770-3E4478D8-E2F0-443D-B076-DFED26BB2755Q49610993-7BD25C30-4044-4D38-939B-EEECEAD18009Q54214258-8B0546C1-695F-4121-A409-E85C18396D12Q55422736-4B7F9CEE-D05A-48CB-A7DC-8CCB5D7CA503Q57487446-E570A3FA-9802-4615-B4B8-A27425ADFA0AQ58369592-4B4E97FC-DCDE-4289-9AB4-FF09B6E7442E
P2860
Development, pharmacology and clinical experience with clomiphene citrate.
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Development, pharmacology and clinical experience with clomiphene citrate.
@ast
Development, pharmacology and clinical experience with clomiphene citrate.
@en
Development, pharmacology and clinical experience with clomiphene citrate.
@nl
type
label
Development, pharmacology and clinical experience with clomiphene citrate.
@ast
Development, pharmacology and clinical experience with clomiphene citrate.
@en
Development, pharmacology and clinical experience with clomiphene citrate.
@nl
prefLabel
Development, pharmacology and clinical experience with clomiphene citrate.
@ast
Development, pharmacology and clinical experience with clomiphene citrate.
@en
Development, pharmacology and clinical experience with clomiphene citrate.
@nl
P356
P1476
Development, pharmacology and clinical experience with clomiphene citrate.
@en
P2093
Holtkamp DE
P304
P356
10.1093/HUMUPD/2.6.483
P577
1996-11-01T00:00:00Z